Search
for

    Glossary Tocilizumab

    medication that inhibits IL-6 receptor to reduce inflammation

    Tocilizumab, also known by the brand name Actemra, is a medication that targets the interleukin-6 (IL-6) receptor, which plays a role in the body's immune response. It is commonly used to treat autoimmune conditions such as rheumatoid arthritis and has also been explored for use in managing severe cases of COVID-19. By inhibiting IL-6, Tocilizumab helps reduce inflammation and modulate the immune system.

    Sort by

    Research 30 of 124

    1. Halo naevi, vitiligo and diffuse alopecia areata associated with tocilizumab therapy Oxford Medical Case Reports · 2016 · 10 citations
    2. Hair-cycle changes in two patients taking tocilizumab Joint Bone Spine · 2013 · 6 citations
    3. Hair Growth in a Patient with Alopecia Areata on Tocilizumab Skin appendage disorders · 2021 · 1 citations
    4. EVIDÊNCIAS ACERCA DO USO DO ANTICORPO MONOCLONAL TOCILIZUMABE COMO TERAPÊUTICA PARA COVID-19 Amplla Editora eBooks · 2022
    5. Telogen effluvium related to post severe Sars‐Cov‐2 infection: Clinical aspects and our management experience Dermatologic Therapy · 2020 · 35 citations
    6. Commonalities Between COVID-19 and Radiation Injury Radiation Research · 2020 · 18 citations
    7. ACTH as first line treatment for acute calcium pyrophosphate crystal arthritis in 14 hospitalized patients Joint Bone Spine · 2013 · 14 citations
    8. Polymorphism of genes in patients with new coronavirus infection COVID-19 Infectious diseases News Opinions Training · 2022 · 8 citations
    9. Lichen Planopilaris in Children: A Systematic Review Pediatric Dermatology · 2024 · 3 citations
    10. Unravelling Beau's lines as a potential indicator of severe immune response in COVID-19 and reinfection European Journal of Case Reports in Internal Medicine · 2024 · 2 citations
    11. Adverse Effects and Drug Interactions of Biologic Agents Anti-inflammatory & anti-allergy agents in medicinal chemistry · 2010
    12. Drug News ​​​​​​​​​​​​​​Nursing2023 · 2017
    13. Social media for arthritis-related comparative effectiveness and safety research and the impact of direct-to-consumer advertising Arthritis research & therapy · 2017 · 20 citations
    14. New developments in the treatment of systemic lupus erythematosus Pediatric Nephrology · 2011 · 15 citations
    15. The Potential of Cannabidiol for Acute Respiratory Distress Syndrome inCOVID-19 Current Pharmaceutical Design · 2023
    16. COVID-19: How Effective Are the Repurposed Drugs and Novel Agents in Treating the Infection? Sudan Journal of Medical Sciences · 2022
    17. Reporting on Adverse Clinical Events Clin-Alert · 2021
    18. Psoriatic Skin Lesions Induced by Certolizumab Pegol Archives of Dermatology · 2010 · 21 citations
    19. Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer Communications biology · 2020 · 113 citations
    20. An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner Stem Cell Reviews and Reports · 2020 · 59 citations
    21. SARS‐CoV‐2‐induced telogen effluvium: a multicentric study Journal of the European Academy of Dermatology and Venereology · 2020 · 51 citations
    22. Telogen Effluvium after SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms Skin appendage disorders · 2021 · 28 citations
    23. Immune cell regulation of the hair cycle Experimental Dermatology · 2020 · 27 citations
    24. Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge Journal of Medical Virology · 2021 · 25 citations
    25. Applications and Implications of Heparin and Protamine in Tissue Engineering and Regenerative Medicine BioMed Research International · 2014 · 15 citations
    26. COVID-19 infection leading to acute pustular dermatoses Archives of Dermatological Research · 2022 · 12 citations
    27. Cutaneous Manifestations in COVID-19: Report on 31 Cases from Five Countries Biology · 2021 · 7 citations
    28. Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development Clinical Pharmacokinetics · 2023 · 6 citations
    29. To evaluate the role of interleukin-6 in alopecia areata Journal of the Pakistan Medical Association · 2024 · 5 citations
    30. Dermatologic Adverse Events from Cancer Treatments Springer eBooks · 2018 · 2 citations